Search Results - "Bourdette, D."

Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE by Chaudhary, P., Marracci, G.H., Calkins, E., Pocius, E., Bensen, A.L., Scanlan, T.S., Emery, B., Bourdette, D.N.

“…We have previously demonstrated that thyromimetics stimulate oligodendrocyte precursor cell differentiation and promote remyelination in murine demyelination…”
Get full text

Body-worn motion sensors detect balance and gait deficits in people with multiple sclerosis who have normal walking speed by Spain, R.I, St. George, R.J, Salarian, A, Mancini, M, Wagner, J.M, Horak, F.B, Bourdette, D

“…Highlights ► Stopwatch-timed mobility tests are insensitive to mild multiple sclerosis (MS). ► We compared timed mobility tests with instrumented body-worn…”
Get full text

Randomized controlled trial of yoga and exercise in multiple sclerosis by OKEN, B. S, KISHIYAMA, S, ZAJDEL, D, BOURDETTE, D, CARLSEN, J, HAAS, M, HUGOS, C, KRAEMER, D. F, LAWRENCE, J, MASS, M

“…To determine the effect of yoga and of aerobic exercise on cognitive function, fatigue, mood, and quality of life in multiple sclerosis (MS). Subjects with…”
Get full text

NMDA receptor encephalitis mimicking seronegative neuromyelitis optica by Kruer, M C, Koch, T K, Bourdette, D N, Chabas, D, Waubant, E, Mueller, S, Moscarello, M A, Dalmau, J, Woltjer, R L, Adamus, G

Get full text

Clinical trial of a formal group fatigue program in multiple sclerosis by Hugos, CL, Copperman, LF, Fuller, BE, Yadav, V., Lovera, J., Bourdette, DN

“…Fatigue: Take Control is a novel program to teach fatigue management to people with multiple sclerosis (MS) following recommendations in the Fatigue and…”
Get full text

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial by Lovera, JF, Frohman, E., Brown, TR, Bandari, D., Nguyen, L., Yadav, V., Stuve, O., Karman, J., Bogardus, K., Heimburger, G., Cua, L., Remingon, G., Fowler, J., Monahan, T., Kilcup, S., Courtney, Y., McAleenan, J., Butler, K., Wild, K., Whitham, R., Bourdette, D.

“…Background: Memantine, an NMDA antagonist, is effective for moderate to severe Alzheimer’s disease. Objective: Determine whether memantine improves cognitive…”
Get full text

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study by Bermel, RA, Weinstock-Guttman, B., Bourdette, D., Foulds, P., You, X., Rudick, RA

“…Disease-modifying drugs are initiated early and continued for years in patients with multiple sclerosis. Long-term tolerability and impact are not known. The…”
Get full text

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis by CREE, B. A. C, KHAN, O, HAINES, J. L, PERICAK-VANCE, M, DELOA, C, OKSENBERG, J. R, HAUSER, S. L, BOURDETTE, D, GOODIN, D. S, COHEN, J. A, MARRIE, R. A, GLIDDEN, D, WEINSTOCK-GUTTMAN, B, REICH, D, PATTERSON, N

“…African American (AA) individuals are thought to develop multiple sclerosis (MS) less frequently than Caucasian American (CA) individuals. To compare the…”
Get full text

American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study by Kim, E, Cameron, M, Lovera, J, Schaben, L, Bourdette, D, Whitham, R

“…This study examined the safety and efficacy of an escalating dose (100 mg, 200 mg, 400 mg/day) of American ginseng over 6 weeks in a single-center, randomized,…”
Get full text

Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis by Shinto, L, Marracci, G, Baldauf-Wagner, S, Strehlow, A, Yadav, V, Stuber, L, Bourdette, D

“…Abstract Objectives The primary objective was to evaluate the effect of omega-3 fatty acids (omega-3 FA) on matrix metalloproteinase-9 (MMP-9) production by…”
Get full text

Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial by Lovera, J., Bagert, B., Smoot, K., Morris, C.D., Frank, R., Bogardus, K., Wild, K., Oken, B., Whitham, R., Bourdette, D.

“…Objectives To determine if Ginkgo biloba (GB) improves the cognitive performance of subjects with multiple sclerosis (MS). Methods Randomized, double-blind,…”
Get full text

Change in quality of life in patients with relapsing–remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon β-1a by Miller, DM, Weinstock-Guttman, B, Bourdette, D, You, X, Foulds, P, Rudick, RA

“…Background: A randomized, placebo-controlled, multicenter study of weekly intramuscular injections of interferon beta-1a (IFNβ-1a) in relapsing–remitting…”
Get full text

Lipoic acid stimulates cAMP production in T lymphocytes and NK cells by Schillace, R.V., Pisenti, N., Pattamanuch, N., Galligan, S., Marracci, G.H., Bourdette, D.N., Carr, D.W.

“…The anti-oxidant lipoic acid (LA) potently suppresses clinical and pathologic disease in the animal model of multiple sclerosis, experimental autoimmune…”
Get full text

NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICA by KRUER, M. C, KOCH, T. K, BOURDETTE, D. N, CHABAS, D, WAUBANT, E, MUELLER, S, MOSCARELLO, M. A, DALMAU, J, WOLTJER, R. L, ADAMUS, G

Get full text

Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis by Shinto, L, Yadav, V, Morris, C, Lapidus, J A, Senders, A, Bourdette, D

“…Complementary and alternative medicine (CAM) use is high among people with multiple sclerosis (MS), yet there are no reports on the association between CAM use…”
Get full text

A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis by Bourdette, D N, Edmonds, E, Smith, C, Bowen, J D, Guttmann, C RG, Nagy, Z P, Simon, J, Whitham, R, Lovera, J, Yadav, V, Mass, M, Spencer, L, Culbertson, N, Bartholomew, R M, Theofan, G, Milano, J, Offner, H, Vandenbark, A A

“…Background: T cell receptor (TCR) peptide vaccination is a novel approach to treating multiple sclerosis (MS). The low immunogenicity of previous vaccines has…”
Get full text

Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis by Chaudhary, Priya, Marracci, Gail H., Bourdette, Dennis N.

“…Lipoic acid (LA) suppresses and treats murine experimental autoimmune encephalomyelitis (EAE), which models multiple sclerosis. However, the mechanisms by…”
Get full text

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis by RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Get full text

The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosis by Shinto, L., Yadav, V., Morris, C., Lapidus, J.A., Senders, A., Bourdette, D.

“…To describe the perceived benefit and satisfaction from complementary and alternative medicine (CAM) and conventional therapies and providers in MS…”
Get full text

FP39-WE-02 A 15-year follow-up study to identify early predictors of long-term response to intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis by Bermel, R.A, Rudick, R.A, Hyde, R, Weinstock-Guttman, B, Bourdette, D, Pace, A, Foulds, P

Get full text